Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KINSHIP: AQX-1125 in atopic dermatitis
NCT02324972Phase 2Completed
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in atopic dermatitis (AD), sponsored by Aquinox Pharmaceuticals. Started Dec 2014; status: completed.
02
Drugs
rosiglitazone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02324972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324972.